ArticleJournal of personalized medicine2024

Prognostic Value of KRAS Mutations in Relation to PDL1 Expression and Immunotherapy Treatment in Adenocarcinoma and Squamous Cell Carcinoma Patients: A Greek Cohort Study.

Theodora Tsiouda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.